| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/17/2013 | CN103041095A Preparation method of Chinese yam capsules |
| 04/17/2013 | CN103041089A Chinese herbal medicine for lowering lipid and dissolving thrombus |
| 04/17/2013 | CN103041070A Lipid-lowering and pressure-releasing folium ginkgo health-care product and preparation method thereof |
| 04/17/2013 | CN103041069A Pure Chinese medicinal composition for hyperlipidemia obesity and preparation method thereof |
| 04/17/2013 | CN103041065A Traditional Chinese medicine composition for reducing blood fat |
| 04/17/2013 | CN103041061A Stasis-dissolving and pulse-invigorating powder |
| 04/17/2013 | CN103041055A Hypoglycemic dispersible tablet and processing technology thereof |
| 04/17/2013 | CN103040983A Traditional Chinese medicine for preventing and/or treating premonitory apoplexy and preparation method thereof |
| 04/17/2013 | CN103040973A Compound Chinese patent drug for treatment of hyperlipoidemia |
| 04/17/2013 | CN103040971A Dealcoholic liver-protecting preparation and preparation process thereof |
| 04/17/2013 | CN103040953A Method for treating diabetes |
| 04/17/2013 | CN103040951A Method for extracting buckwheat flavonoids |
| 04/17/2013 | CN103040937A Perhexiline lipidosome injection |
| 04/17/2013 | CN103040917A Method for preparing total saponins and polysaccharides from Apios americana flowers simultaneously, and application of total saponins and polysaccharides |
| 04/17/2013 | CN103040914A Preparation method of eucommia ulmoides seed oil nano emulsion injection |
| 04/17/2013 | CN103040880A Separation and purification method of tribulus terrestris saponin |
| 04/17/2013 | CN103040864A Medical application of selenium phosphate compound |
| 04/17/2013 | CN103040851A Application of Houttuynoid A in preparation of blood sugar reducing medicines |
| 04/17/2013 | CN103040845A Fat emulsion injection for supplementing fat-soluble vitamins |
| 04/17/2013 | CN103040844A Two-dimensional calcium acetate composition |
| 04/17/2013 | CN103040821A Application of berberine in pharmacy |
| 04/17/2013 | CN103040815A Application of 2,4,6-triisopropylbenzene compounds in preparation of medicines for treating diabetes |
| 04/17/2013 | CN103040799A Application of non-steroidal anti-inflammatory medicines in preparation of medicine for preventing and treating diabetic encephalopathy |
| 04/17/2013 | CN103040790A Preparation method of wild cactus polysaccharide poly(lactic-co-glycolic acid) (PLGA) microcapsules |
| 04/17/2013 | CN103040772A Repaglinide dispersible tablet and preparation method thereof |
| 04/17/2013 | CN103040761A Novel metformin hydrochloride sustained release pellets and preparation method thereof |
| 04/17/2013 | CN103040759A Sustained-release oral solid preparation by using vildagliptin as active component |
| 04/17/2013 | CN103040730A Iron sucrose injection and preparation method thereof |
| 04/17/2013 | CN102640918B Preparation method of ant, burdock and ganoderma lucidum liquid |
| 04/17/2013 | CN102631357B Composite tablet of valsartan and hydrochlorothiazide and preparation method thereof |
| 04/17/2013 | CN102524514B Use of wheat germ active polypeptide in preparation health product for controlling nutritious fat, food and medicine |
| 04/17/2013 | CN102488714B Gallnut aphid oil composition, preparation method and application of gallnut aphid oil composition |
| 04/17/2013 | CN102488667B Glimepiride tablet and preparation method thereof |
| 04/17/2013 | CN102462690B Application of 3,8,12,14,17,20-position oxygen-substituted pregnene glycoside compound in preparing medicine for appetite inhibition |
| 04/17/2013 | CN102335182B Application of triacetylglucal in medicine preparation |
| 04/17/2013 | CN102319263B Film coated tablets containing a plurality of vitamins and mineral matters, and its preparation process |
| 04/17/2013 | CN102302489B Preparation method of compound amino acid injection |
| 04/17/2013 | CN102247370B Compound repaglinide-metformin hydrochloride controlled release preparation |
| 04/17/2013 | CN102228513B Medicinal composition for treating diabetes or diabetic complications and preparation method thereof |
| 04/17/2013 | CN102225165B Traditional Chinese medicine granule for treating type II diabetes |
| 04/17/2013 | CN102210739B Method for extracting total saponins and total flavonoids from alfalfa and preparation method thereof |
| 04/17/2013 | CN102199157B Bromine-containing benzopyran compound and preparation and application thereof |
| 04/17/2013 | CN102166294B Common Anemarrhena asphodeloides extract with immunosuppressive activity and preparation method and medicinal purposes thereof |
| 04/17/2013 | CN101993485B Peptide analog homologous dimer capable of accelerating insulin secretion and application thereof |
| 04/17/2013 | CN101987813B Chemical total synthesis method for diabetes type II resistant medicament hypnopyrine |
| 04/17/2013 | CN101984974B Preparation method of pharmaceutical composition for treating type II diabetes |
| 04/17/2013 | CN101967205B Beta-dextriferron composite and preparation method thereof |
| 04/17/2013 | CN101921309B L-cystyl-2-L-aspartic tripeptide and derivatives, preparation method and application thereof |
| 04/17/2013 | CN101899048B Salt of (R)-7-[3-amino-4-(2,4,5-trifluoro-phenyl)-butyryl]-3-trifluoromethyl-5,6,7,8-tetrahydro-imidazo[1,5-a]pyrazine-1- carboxylic acid methyl ester |
| 04/17/2013 | CN101884398B Chromium-enriched wheat bran and preparation method thereof |
| 04/17/2013 | CN101831369B Golden fungus gingko yellow wine, preparation method and efficacy thereof |
| 04/17/2013 | CN101480403B Medicament composition and preparation method thereof |
| 04/17/2013 | CN101361754B Use of rare-earth element salt or pharmaceutical composition thereof in preparing medicine for treating or preventing diabetes and adiposis |
| 04/17/2013 | CN101150956B Formulations for injection of catecholic butanes, including NDGA compounds, into animals |
| 04/17/2013 | CN101150955B Oral formulations for delivery of catecholic butanes including NDGA compounds |
| 04/16/2013 | US8420810 Bicyclic heterocyclic compound |
| 04/16/2013 | US8420679 Aminothiazole derivatives and their use as CRF receptor ligands |
| 04/16/2013 | US8420642 Pyridine derivatives useful as glucokinase activators |
| 04/16/2013 | US8420641 Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives |
| 04/16/2013 | US8420631 Serotonin receptor antagonist; therapy for obesity, antidepressants, obsessive-compulsive disorders |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | US8420082 Neutralizing antibodies against GDF-8 and uses therefor |
| 04/16/2013 | CA2723494C 2-methyl piperazine derivatives for treatment of serotonin-related disorders |
| 04/16/2013 | CA2476846C Method for detection of leptin receptor ligands |
| 04/11/2013 | WO2013052647A2 Formulations and uses of retinoic acid receptor selective agonists |
| 04/11/2013 | WO2013052507A1 TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS BY PHARMACOLOGICAL TARGETING OF Kv1.3 POTASSIUM CHANNELS |
| 04/11/2013 | WO2013051632A1 Nitrogen-containing fused heterocyclic compound |
| 04/11/2013 | WO2013051459A1 Promoter capable of promoting inhibition of expression of mrna by rna interference, and use thereof |
| 04/11/2013 | WO2013051159A1 Nop receptor antagonist |
| 04/11/2013 | WO2013037985A8 Pharmaceutical combinations including anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders |
| 04/11/2013 | WO2013015535A3 Novel pyrimidine derivative and pharmaceutical composition including same as an active ingredient |
| 04/11/2013 | WO2013010048A3 Non-standard insulin analogues |
| 04/11/2013 | WO2013002580A3 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient |
| 04/11/2013 | WO2012174478A3 Stable formulations of a hyaluronan-degrading enzyme |
| 04/11/2013 | WO2012174229A3 Methods for the synthesis and purification of deoxycholic acid |
| 04/11/2013 | WO2012170438A3 HUMAN ANTIGEN BINDING PROTEINS THAT BIND TO A COMPLEX COMPRISING β-KLOTHO AND AN FGF RECEPTOR |
| 04/11/2013 | WO2012020308A3 Pancreatic duct progenitor cells and microrna obtained therefrom for use in tissue regeneration |
| 04/11/2013 | WO2007056907A9 TRUNCATED GLUCAGON-LIKE PEPTIDE-1 (sGLP-1) AND ITS PREPARING METHOD AND USE |
| 04/11/2013 | US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof |
| 04/11/2013 | US20130089528 Compositions and methods for preserving insulin-producing cells and insulin production and treating diabetes |
| 04/11/2013 | CA2850919A1 Choline composition |
| 04/11/2013 | CA2850357A1 Treatment of obesity and obesity-related disorders by pharmacological targeting of kv1.3 potassium channels |
| 04/11/2013 | CA2850223A1 Control of whole body energy homeostasis by microrna regulation |
| 04/10/2013 | EP2578677A1 Method of treating autoimmune disease with mesenchymal stem cells |
| 04/10/2013 | EP2578586A1 HEXAHYDROPYRROLO[3,4-b]PYRROLE DERIVATIVES, PREPARATION METHODS AND PHARMACEUTICAL USES THEREOF |
| 04/10/2013 | EP2578574A1 Optically active dibenzylamine derivative, and manufacturing method for same |
| 04/10/2013 | EP2578219A1 Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 04/10/2013 | EP2576618A1 Antibodies to human gdf8 |
| 04/10/2013 | EP2576576A1 Heterocyclyl-pyridinyl-based biphosphonic acid, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof |
| 04/10/2013 | EP2576559A1 Inhibitors of jnk |
| 04/10/2013 | EP2576549A2 Bicyclic heteroaryl kinase inhibitors and methods of use |
| 04/10/2013 | EP2576545A1 Nitrate and diazeniumdiolate derivatives of pioglitazone |
| 04/10/2013 | EP2576537A1 2 -amino- pyrimidine derivatives useful as inhibitors of jnk |
| 04/10/2013 | EP2575865A1 Pharmaceutical composition comprising ave0010 and insulin glargine |
| 04/10/2013 | EP2575860A1 Diagnostic, screening and therapeutic applications of ocab-based tools |
| 04/10/2013 | EP2575859A1 Methods of treating diabetes and compositions capable of same |
| 04/10/2013 | EP2575858A2 Methods for treatment of nephrotic syndrome and related conditions |
| 04/10/2013 | EP2575856A2 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-trna synthetases |
| 04/10/2013 | EP2575842A2 A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases |
| 04/10/2013 | EP2575826A1 Anti-diabetic compositions and methods |